Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


2nd Novel Immunotherapeutics Summit

30 Jan 2013 - 01 Feb 2013 - San Diego, CA, USA



Bookmark and Share


The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity, immunotoxicity, allergy and asthma will be discussed at the summit. The summit includes four concurrent tracks.  In addition, an optional workshop will be held on Jan 30, 2013. 


2nd Novel Immunotherapeutics Summit: 
     Workshop: Immune Responses in Tumor Microenvironment
     Track: 5th Immunotherapeutics & Immunomonitoring
     
Track: 11th Cytokines & Inflammation
     
Track: 2nd Allergy Research & Drug Discovery
     
Track: Immunogenicity & Immunotoxicity 



Network with representatives from prestigious organizations and discuss the latest research from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk, Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme, Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San Francisco, and many more!

Click here to register for the 2nd Novel Immunotherapeutics Summit

Call for Papers!
To be considered for an oral presentation, please submit an abstract here by December 31, 2012. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.

Sponsorship and exhibiting opportunities are available, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or gtcsales@gtcbio.com for more information.



Further information
Scientific News
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!